Valneva Archives -

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

Valneva has moved a step closer to its goal of becoming the first company to file for approval

Valneva eyes first place in chikungunya vaccine race

https://pharmaphorum.com/news/valneva-eyes-first-place-in-chikungunya-vaccine-race/

Infected female deer tick on hairy human skin. Ixodes ricinus. Dangerous mite detail. Acarus. Infectious borreliosis

News/ News/ R&D

Pfizer takes stake in French Lyme disease jab partner Valneva

Phil Taylor Lyme disease, partnering, Pfizer, vaccine, Valneva 0 Comment

Pfizer has acquired an 8.1% stake in French vaccines developer Valneva at a cost of €90.5 million (around

Pfizer takes stake in French Lyme disease jab partner Valneva

https://pharmaphorum.com/news/pfizer-takes-stake-in-french-lyme-disease-jab-partner-valneva/

News/ News/ R&D

Readout sets up phase 3 for Valneva/Pfizer’s Lyme disease jab

Phil Taylor infectious diseases, Lyme disease, Pfizer, vaccine, Valneva 0 Comment

There’s only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer’s VLA15

Readout sets up phase 3 for Valneva/Pfizer’s Lyme disease jab

https://pharmaphorum.com/news/readout-sets-up-phase-3-for-valneva-pfizers-lyme-disease-jab/

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

News/ News/ Patients

COVID booster shots increase immunity, trial shows

Joy Persaud AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, CureVac, Janssen, Moderna, NHS, Novavax, Omicron, Pfizer, UK, Valneva 0 Comment

A trial of booster vaccinations to protect against COVID-19 has shown that the jab significantly strengthens the body’s

COVID booster shots increase immunity, trial shows

https://pharmaphorum.com/news/covid-booster-shots-increase-immunity-trial-shows/

News/ News/ R&D

Pharma pledges rapid response to Omicron COVID variant

Phil Taylor AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Novavax, Omicron, Pfizer, Valneva, variant 0 Comment

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened

Pharma pledges rapid response to Omicron COVID variant

https://pharmaphorum.com/news/pharma-pledges-rapid-response-to-omicron-covid-variant/

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

News/ News/ Sales and Marketing

Valneva gets EU deal for COVID jab, and may sue UK

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, EU, Sales and Marketing, UK, Valneva 0 Comment

Shares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its

Valneva gets EU deal for COVID jab, and may sue UK

https://pharmaphorum.com/news/valneva-gets-eu-deal-for-covid-jab-and-may-sue-uk/

News/ News/ R&D

Booster data backs Pfizer, Valneva Lyme disease vaccine

Phil Taylor infectious disease, Lyme disease, Pfizer, vaccine, Valneva 0 Comment

Prospects for Valneva’s COVID-19 vaccine are up in the air, but another candidate partnered with Pfizer looks increasingly

Booster data backs Pfizer, Valneva Lyme disease vaccine

https://pharmaphorum.com/news/booster-data-backs-pfizer-valneva-lyme-disease-vaccine/

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

News/ News/ Sales and Marketing/ Top stories

EU ‘negotiating with Valneva’ over COVID-19 vaccine contract

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, MHRA, UK, Valneva 0 Comment

The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to

EU ‘negotiating with Valneva’ over COVID-19 vaccine contract

https://pharmaphorum.com/news/eu-negotiating-with-valneva-over-covid-19-vaccine-contract/

News/ News/ Sales and Marketing

Valneva slumps as UK dumps €1.4bn order for COVID-19 jab

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, MHRA, UK, Valneva 0 Comment

The UK has terminated its order for up to 190 million doses of a COVID-19 vaccine developed by

Valneva slumps as UK dumps €1.4bn order for COVID-19 jab

https://pharmaphorum.com/news/valneva-slumps-as-uk-dumps-e1-4bn-order-for-covid-19-jab/

Trending

Valneva

Login